Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tests better ways to fix receding gums

NCT ID NCT05565079

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study involved 24 adults with receding gums to see if adding an enamel protein to a standard gum graft procedure improves results. The standard method uses a tissue graft placed under the gum with a small tunnel. Half the participants also got the enamel protein. Researchers measured gum coverage, attachment, and thickness at the start and after 6 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

24 people

The number who actually took part.

Started

Oct 2022

Finished

Oct 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Presence of at least one Miller class 1 or 2 soft tissue recession defect \>3 mm on a non-molar tooth. * Healthy patients, at least 18 years of age. * Patient understands and signs an informed consent approved by the University of Louisville IRB. Exclusion Criteria: * Patients with debilitating systemic diseases, diseases that significantly affect the periodontium, infectious diseases, or psychological problems that may interfere with treatment. * Previous head and neck radiation or chemotherapy within the previous 12 months. * Patients with known allergies to any of the materials used in the study, including systemic antibiotics. * Patients that use tobacco products (smoking, smokeless tobacco, or electronic cigarettes). * Patients with alcohol abuse problems. * Patients requiring antibiotic prophylaxis for dental procedures. * Cemento-enamel unction not identifiable. * Root surface restorations at the recession site. * Patients undergoing long-term steroid therapy. * History of previous root coverage procedure, graft, or guided tissue regeneration involving the recession site. * Pregnant or lactating patients. * Patients who fail to maintain oral hygiene levels of at least 80% plaque-free surfaces. * Patients who fail to complete the informed consent form.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Recession, gingival are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Louisville

    Louisville, Kentucky, 40202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.